SCHEMBL114094

SCHEMBL114094

O=C(CCN(C(=O)O)c1ccc(OCC(O)c2ccccc2)cc1)Nc1ccc2cnccc2c1

nearest known ligand 0.49

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 2/20 0.49
▸ ROCK2 O75116 10/20 0.48
▸ ROCK1 Q13464 3/20 0.48
▸ NOTUM Q6P988 5/20 0.47
▸ IMPDH2 P12268 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2777629 0.90 NOTUM (0.44) LTA4HROCK2ROCK1NOTUMIMPDH2
SCHEMBL112926 0.84 NOTUM (0.51) LTA4HROCK2ROCK1NOTUMIMPDH2
SCHEMBL113082 0.81 ROCK2 (0.52) ROCK2ROCK1NOTUMIMPDH2
SCHEMBL112509 0.81 NOTUM (0.46) ROCK2ROCK1NOTUMIMPDH2
SCHEMBL16056718 0.80 ROCK2 (0.56) ROCK2ROCK1NOTUMIMPDH2
SCHEMBL115009 0.79 ROCK2 (0.53) ROCK2ROCK1NOTUMIMPDH2
SCHEMBL9883131 0.78 ROCK2 (0.78) ROCK2ROCK1
Hydrochloric Acid SCHEMBL112462 0.77 ROCK2 (0.76) ROCK2ROCK1
SCHEMBL114093 0.76 ROCK2 (0.61) ROCK2ROCK1
SCHEMBL15844181 0.75 NOTUM (0.47) LTA4HROCK2ROCK1NOTUMIMPDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424857-A1 DUAL-ACTION INHIBITORS AND METHODS OF USING SAME Aerie Pharmaceuticals, Inc. (US) 2012-03-07 — — EP disclosed
EP-2424842-A2 DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE Aerie Pharmaceuticals, Inc. (US) 2012-03-07 — — EP disclosed
WO-2010127330-A1 DUAL-ACTION INHIBITORS AND METHODS OF USING SAME AERIE PHAMACEUTICALS, INC. (US) 2010-11-04 — — WO disclosed
WO-2010127329-A1 DUAL-ACTION INHIBITORS AND METHODS OF USING SAME AERIE PHARMACEUTICALS, INC. (US) 2010-11-04 — — WO disclosed
WO-2010126626-A2 DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE AERIE PHARMACEUTICALS, INC. (US) 2010-11-04 — — WO disclosed
Send feedback